How Can Deprescribing Trials Boost Senior Safety and Mobility?
Deprescribing trials reduce polypharmacy harms and restore mobility for older adults. This analysis links trial design, fall-prevention, immune strategies, caregiver-friendly dementia options, and global regulatory and outcome metrics for actionable practice change.
Robert Maxwell
Sep 29, 2025
geriatric oncology
polypharmacy deprescribing
falls prevention
late-life depression
